Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder

Annals of the New York Academy of Sciences

Volumn 1018, Issue , 2004, Pages 505-514

  Esler, Murray ^a   Alvarenga, Marlies ^b   Lambert, Gavin ^a   Kaye, David ^a   Hastings, Jacqui ^a   Jennings, Garry ^a   Morris, Margaret ^c   Schwarz, Rosemary ^d   Richards, Jeff ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d NONE   (Australia)

Author keywords

Heart risk; Mental stress; Neuropeptide Y; Serotonin; Sympathetic cotransmission

Indexed keywords

BRAIN MONOAMINE; HYDROCORTISONE; NEUROPEPTIDE Y; NORADRENALIN; PHENYLETHANOLAMINE N METHYLTRANSFERASE; SEROTONIN;

ADRENERGIC TRANSMISSION; ANGINA PECTORIS; CARDIOVASCULAR RISK; CONFERENCE PAPER; CORONARY ARTERY SPASM; CORONARY ARTERY THROMBOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ELECTROCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; GENETIC PREDISPOSITION; HEART ATRIUM FIBRILLATION; HEART INNERVATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MONOAMINE METABOLISM; NEUROPATHOLOGY; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PANIC; PATHOPHYSIOLOGY; RISK ASSESSMENT; SEROTONIN BLOOD LEVEL; SEROTONIN BRAIN LEVEL; SYMPATHETIC INNERVATION; SYMPATHETIC TONE;

ANGINA;

EID: 3242710308     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1296.062     Document Type: Conference Paper

References (22)

1. AMERICAN PSYCHIATRIC ASSOCIATION. 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. American Psychiatric Association. Washington, DC.
2. KAWACHI, I., D. SPARROW, P.S. VOKANAS, et al. 1994. Symptoms of anxiety and coronary heart disease: the normative aging study. Circulation 90: 2225-2229.
3. KAWACHI, I., G.A. COLDITZ, A. ASCHERIO, et al. 1994. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89: 1992-1997.
4. ROZANSKI, A., J.A. BLUMENTHAL & J. KAPLAN. 1999. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99: 2192-2217.
5. ESLER, M.D. 1998. Mental stress, panic disorder and the heart. Stress Med. 14: 237-243.
6. WILKINSON, D.J.C., J. THOMPSON, G.W. LAMBERT, et al. 1998. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress and during panic attacks. Arch. Gen. Psychiatry 55: 511-520.
7. GRATACOS, M., M. NADAL, R. MARTIN-SANTOS, et al. 2001. A polymorphic genomic duplication in human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106: 367-379.
8. ESLER, M., M. ALVARENGA, D. KAYE, et al. 2004. Primer of the Autonomic Nervous System. D. Robertson, P.A. Low, G. Burnstock & E. Biaggioni, Eds. Elsevier Science. San Diego.
9. ESLER, M., G. JENNINGS, G. LAMBERT, et al. 1990. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol. Rev. 70: 963-985.
10. ESLER, M., G. WALLIN, P. DORWARD, et al. 1991. Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in man. Am. J. Physiol. 260: R817-R823.
11. KVETNANSKY, R., L. MICUTKOVA, M. PALKOVITS, et al. 2003. Regulation of cardiac phenylethanolamine-n-methyltransferase gene expression in rat during stress. Endocr. Regul. 37: 112 (abstract).
12. MANSOUR, V.M., D.J.C. WILKINSON, G.L. JENNINGS, et al. 1998. Panic disorder: coronary spasm as a basis for coronary risk? Med. J. Aust. 168: 390-392.
13. HASS, M. 1998. Neuropeptide Y: a cardiac sympathetic cotransmitter? In Catecholamines - Bridging Basic Science with Clinical Medicine. D.S. Goldstein & R. McCarthy, Eds.: 129-132. Academic Press. New York.
14. SINGEWALD, N., S. KAEHLER, R. HEMEIDA, et al. 1997. Release of serotonin in the rat locus coeruleus: effects of cardiovascular, stressful and noxious stimuli. Eur. J. Neurosci. 9: 556-562.
15. LAMBERT, G.W., D.M. KAYE, H.S. COX, et al. 1995. Regional 5-hydroxyindoleacetic acid production in humans. Life Sci. 57: 255-267.
16. TORK, I. 1990. Anatomy of the serotonergic system. Ann. N.Y. Acad. Sci. 600: 9-35.
17. LAMBERT, G.W., D.M. KAYE, M. VAZ, et al. 1995. The influence of sympathetic nervous activation on the regional production of 3-methoxy-4-hydroxyphenylglycol in humans. J. Auton. Nerv. Syst. 55: 169-178.
18. LAMBERT, G.W., M. VAZ, H.S. COX, et al. 1999. Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover. Clin. Sci. 96: 191-197.
19. LAMBERT, G.W., C. REID, D.M. KAYE, et al. 2002. Effect of sunlight and season on serotonin turnover in the brain. Lancet 360: 1840-1842.
20. TECOTT, L.H., L.M. SUN, S.F. AKANA, et al. 1995. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374: 542-546.
21. KENNAWAY, D.J. & R.W. MOYER. 1998. Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms. Brain Res. 806: 257-270.
22. WILDE, M.I., G.L. PLOSKER & P. BENFIELD. 1993. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness. Drugs 46: 895-924.